Effortless healing, seamless wound remodeling
Ping Bao Biotechnology Co., Ltd., was established in 2015 and has been devoting to the research and development of new hydrogel dressings ever since. In 2018, Ping Bao Biotech’s innovation is patented in Taiwan. This unique technology enables our hydrogel dressing maintain up to 95% water content without sacrificing its high absorption, permeability, biocompatibility and usability. Thus, our product has a critical impact in wound care market, especially in the stage of postoperative care, or ageing-associated complications such as decubitus, diabetic foot, venous ulcers, etc. The immediate goal of our company is to cooperate with Taiwanese dressing laboratories to produce hydrogels for medical applications and solidify our reputation in the international markets. The long-term goal is to develop various related products based on our new technology, such as functional composite hydrogel products with drugs additives and hydrogel applications for subcutaneous repair, etc. With these ambitions, Ping Bao will keep pursuing excellence and play a crucial role in coming medical era.
Vision
Goal
Strategy
Technology
World Collaboration
Ping Bao Biotech expects the potential distribution partners from all over the world to join us to promote hydrogel dressings together. Through cooperation, not only can we increase the margins in the wound care market, but also decrease the burden of the medical staff and improve quality of health care. At present, our company has actively advocated in the research of advanced wound dressing materials, and simultaneously cooperated with many domestic and international medical manufacturers and R&D units to develop chronic wound dressings and percutaneous absorption drug-loading platforms. We continue to upgrade the quality and function of our products and develop medical products for trauma care. In this way, a comprehensive wound caring system can be constructed soundly. With its corporate reputation, diversified products and consumer demand, Ping Bao Biotech has entered the medical industry and expanded into the market for drug-containing dressing compound medical products. We are looking forward to working together with you to make wound care no longer difficult.
Evolution
- 2015.05
- Establishment of Ping Bao Biotech
- 2015.06-07
- ISO 10993 Testing (Irritation Test, In Vitro Cytotoxicity Test, Skin Sensitization Study, Pyrogens Test) and Antimicrobial Effectiveness Testing — AATCC100TEST
- 2015.09
- Green Guard General Purpose Disinfectants obtained TFDA Medical Device License
- 2015.12
- Green Guard Hydrogel Wound Dressing obtained TFDA Medical Device License
- 2015.12
- EV71 antimicrobial effectiveness testing accomplished
- 2017.05
- Develop New CCD Hydrogel powder application to inter body fusion system
- 2018.02
- Commission of industry-academia collaboration of animal's tests with National Taiwan University College of Medicine
- 2018.06
- Agency agreement with ES Singapore Consultancy and product registration in Singapore
- 2018.08
- Green Guard Oral Hydrogel Dressing (Sterile) obtained TFDA Medical Device License
- 2018.12
- Green Guard Hydrogel Dressing (Sterile) obtained TFDA Medical Device License
- 2019.10
- Green Guard Hydrogel Wound Dressing (Non sterile) product was awarded Class C of HSA Medical Device License in October 2019.
- 2022.02
- Green Guard Hydrogel Wound Dressing (Non sterile) product was awarded Class C of Kiwa International Certification (M) Sdn. Bhd. Medical Device License in Feb 2022.
- 2023.04
- Green Guard Hydrogel Wound Dressing (Non sterile) product was awarded Class B of Republic of the Philippines Department of Health FDA Medical Device License.
- 2023.09
- Effortless healing, Seamless wound remodeling: Introduction on the Clinical Experience and Discussion on the Use of Green Guard Hydrogel in Acute and Chronic Wounds